ライフサイエンスコーパス: TLR4

1 her CD61(+) platelets, and most of them were TLR4(+) .

2 after deletion of the Toll-like receptor 4 (TLR4).

3 retion is dependent on toll-like receptor 4 (TLR4).

4 ceptors, toll-like receptor-2 (TLR2) and -4 (TLR4).

5 te immune response via toll-like receptor 4 (TLR4).

6 ated partially through Toll-like receptor 4 (TLR4).

7 or TLR9, but not upon engagement of TLR3 or TLR4.

8 sma membrane important for LPS signaling via TLR4.

9 mechanistically from IFN-I-induction through TLR4.

10 ic neural precursor cells expressed TLR2 and TLR4.

11 en species (ROS) generation independently of TLR4.

12 ytokine production triggered through NOD1 or TLR4.

13 following prenatal activation of TLR3 and/or TLR4.

14 feron (IFN) gene transcription downstream of TLR4.

15 This reduction was reversed by inhibition of TLR4.

16 rmal shift assay indicated that PCA1 bond to TLR4.

17 egulation of TLR2 expression but not TLR1 or TLR4.

18 with a twofold increase in the expression of Tlr4.

19 ent by change in the expression of CXCR4 and TLR4.

20 These results demonstrate that TLR4/7/9 and NOD2 are involved in either promoting or at

21 258G/A), TLR3 (1377C/T, 1234C/T, and -7C/A), TLR4 (896A/G, 1196C/T, and 3266G/A), and TLR9 (-1237T/C,

22 mal keratinocytes, soy PG inhibited TLR2 and TLR4 activation and inflammatory mediator expression in

23 scape, and mRNA translation with and without TLR4 activation are quantified.

24 TLR4 activation blocks mRNA translation in all tested ce

25 ns and become hyporesponsive after prolonged TLR4 activation by bacterial LPS.

26 n i) LNP uptake and ii) translation suggests TLR4 activation can "override" LNP targeting, even after

27 Here we show that TLR4 activation induces a signalling cascade recruiting

28 However, the mechanisms by which TLR4 activation leads to mitochondrial and glycolytic re

29 Inhibition of pro-inflammatory TLR4 activation represents a new mechanism of 3alpha,5al

30 Dual CD40-TLR4 activation within a single tumor is thus an approac

31 eatment with ATX significantly inhibited the TLR4 activation, increased sirtuin 1 expression, and inh

32 Shortly after TLR4 activation, macrophages increased glycolysis and tr

33 macrophage surface, resulting in blockade of TLR4 activation, prevention of TNF-alpha and IFN-beta pr

34 Following TLR4 activation, TRIM21 was transiently degraded via the

35 ad to hypothesize that toll-like receptor 4 (TLR4) activation reduced LNP-mediated mRNA delivery.

36 tory mediator expression induced by TLR2 and TLR4 activators as well as NFkappaB activation in a macr

37 isoforms is induced by stimulation with the TLR4 agonist lipopolysaccharide (LPS); thus, this altern

38 roximately 0.01% in cells incubated with the TLR4 agonist or distilled water.

39 t stably co-encapsulate CRX-601, a synthetic TLR4 agonist, and UM-3004, a lipidated TLR7/8 agonist, w

40 Monophosphoryl lipid A (MPLA), a detoxified TLR4 agonist, and Wortmannin, a phosphoinositide 3-kinas

41 to that induced by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide.

42 Tumour necrosis factor (TNF), like TLR3 or TLR4 agonists, also induced caspase-8-dependent cleavage

43 In addition to TLR9 agonists, TLR2, TLR3, or TLR4 agonists, as well as TNF-alpha, IL-6, or IL-17A, bu

44 derived dendritic cells activated by NOD1 or TLR4 agonists, except for tumor necrosis factor producti

45 2) (sPLA(2)) are needed for the formation of TLR4 agonists, which were identified as lysophospholipid

46 atile anesthetics directly bound to TLR2 and TLR4 and attenuated their functions.

47 ulation of the pattern recognition receptors TLR4 and Dectin-1.

48 These data suggest that both TLR4 and FN-EDA contribute to TGFbeta2 induced ocular hy

49 thalamic inflammation, which is regulated by Tlr4 and Ikbke signaling.

50 and pro-inflammatory activation genes (e.g. Tlr4 and Il1b).

51 Our results showed that TLR4 and inflammasome pathways are enhanced in low-quali

52 s work demonstrates that co-encapsulation of TLR4 and lipidated TLR7/8 agonists within the liposomal

53 m control and diabetic animals, and measured TLR4 and MD2-a co-receptor that confers functionality to

54 Finally, we found that TLR4 and MYD88 knockdown inhibited PTX3-induced melanoma

55 hemocyanins to the MR and MGL receptors and TLR4 and reduced endocytosis concomitant with an impaire

56 nd messenger mechanisms in common, action at TLR4 and signaling via PKCepsilon, HDM-induced analgesia

57 Mechanistically, EDA FN binds to TLR4 and sustains progenitor cell proliferation and mega

58 We sought to evaluate suppression of the TLR4 and the antiviral retinoic acid-inducible gene-I (R

59 e gene expression and release in response to TLR4 and TLR2 ligand stimulation but not for TLR-indepen

60 In addition, TLR4 and TLR2/4 KO mice demonstrated a significant incre

61 nd (ii) adjuvant activation of innate immune TLR4 and TLR5 pathways.

62 SNPs in TLR4 and TNFA predicted both TST conversion and active T

63 -8 and inhibition of programmed necrosis via TLR4 and TNFR1.

64 AT2, but not LPCAT1, rapidly associates with TLR4 and translocates to membrane lipid raft domains.

65 y-old normoglycemic (prediabetic) female NOD TLR4(+/+) and NOD TLR4(-/-) mice, gut morphology and mic

66 in bone marrow-derived macrophages (BMMs) of TLR4(-/-) and ASC(-/-) mice were significantly greater t

67 flammation and AHR in wild-type, RAGE(-/-) , TLR4(-/-) and TLR4(-/-) RAGE(-/-) mice following acute e

68 HMWH also signals via Toll-like receptor 4 (TLR4), and AS-ODN for TLR4 mRNA administered intrathecal

69 mic microglia density, toll-like-receptor-4 (Tlr4), and the inhibitor-NF-kappa-B-kinase-epsilon (Ikbk

70 tinal inflammation in mice with colitis, via TLR4, and alters their fecal microbiota.

71 n CNS complement cascade proteins (C1q, C3), TLR4, and colabeling with glia (IBA1, GFAP) were examine

72 Increased expression of Atg5, Atg16, Irgm1, Tlr4, and Lyz genes was observed in the IAP treated grou

73 ction triggered by various TLRs (TLR2, TLR3, TLR4, and TLR7), C-type lectin receptors (Dectin-1, Dect

74 , we determined the frequency of TLR2, TLR3, TLR4, and TLR9 single-nucleotide polymorphisms (SNPs) an

75 x vivo Compared with NOD TLR4(+/+) mice, NOD TLR4(-/-) animals showed lower muscle mass of the small

76 fferential effect on seizure susceptibility, TLR4 antagonism suppressed cellular inflammatory respons

77 These data demonstrate that the TLR4 antagonist (+)-naltrexone inhibits the inflammatory

78 ts and treated them with a neutralizing anti-TLR4 antibody for 14 days.

79 and without a pharmacological inhibitor for TLR4 as well as for MD2.

80 priming, neither of which was attenuated by TLR4 AS-ODN.

81 vels of MD2 expression in the aorta, but not TLR4, at least in the conditions evaluated in this study

82 Thus, our data identify the S100A9/TLR4 axis as a putative target for ID care.

83 (~30%), and MCP-1 (~20%) levels, as well as TLR4 binding to GABA(A) receptor alpha2 subunits (~60%)

84 Compared to B6 BMMs, TLR4(-/-) BMMs failed to secrete a significant level of

85 of smoking status on AGER (encodes RAGE) and TLR4 bronchial gene expression in patients with and with

86 Conclusion: Stimulation of TLR4 by LPS activates NF-kappaB to down-regulate ITPR3 e

87 NE and TLR4 colocalized with the parasite in the parasitophorou

88 pathways (i.e., NFkB and CREB) downstream of TLR4 compared to their GIV-depleted counterparts.

89 amplify PAF signaling, we evaluated whether TLR4 contributes to inflammation and fetal loss in a mou

90 ands by the TLRs, either directly or via the TLR4 coreceptors CD14 and MD2.

91 as revealed by pharmacological blockade and TLR4 deficiency in mice.

92 ch favor accelerated diabetes development in TLR4-deficient (TLR4(-/-)) NOD mice.

93 and fetal loss in wild-type mice but not in TLR4-deficient mice.

94 normal healing and myeloid cell function in Tlr4-deficient mice.

95 n mice, whereby ankle swelling was partially TLR4 dependent.

96 ing host immunity in a Toll-like receptor 4 (TLR4)-dependent manner, a signaling pathway that is requ

97 ASC inflammasome via a Toll-like receptor 4 (TLR4)-dependent mechanism.

98 amage-associated molecular pattern, inducing TLR4-dependent cytokine production through the MyD88 pat

99 Moreover, the TLR4-dependent early increase in dentate excitability is

100 of IFN-gamma after S. aureus infection in a TLR4-dependent manner.

101 LPSs of all species induced TLR4-dependent NF-kappaB responses; however, while SDS-P

102 on, suggesting that PTX3 functions through a TLR4-dependent pathway.

103 suggested that Fn-EDA mediates integrin- and TLR4-dependent proliferation and migration through activ

104 pro-caspase-1 and pro-IL-1beta, resulting in TLR4-dependent secretion of IL-1beta.

105 significantly increased in villin-TLR4 mice; TLR4-dependent tumorigenesis required the presence of DU

106 Antibodies against TLR2 or TLR4 did not block the increases in IL1B or TNF expressi

107 t independently of glia, the immune receptor TLR4 directly regulates post-traumatic neuronal excitabi

108 er data sets were analyzed for expression of TLR4, dual oxidase 2 (DUOX2), and NADPH oxidase 1 (NOX1)

109 osis and switches signaling adaptor; surface TLR4 engagement predominantly induces proinflammatory cy

110 ylation and cytokine secretion and increased TLR4-enhanced antimicrobial pathways.

111 B1 contributes to the EDR impairment through TLR4/eNOS pathway in the setting of diabetes.

112 While differences in TLR4 expression did not appear to explain these data, F4

113 TLR4 expression did not correlate with neutrophilic infl

114 l1(f/f)Lyz2(Cre+) ) to determine MLL1 drives Tlr4 expression during wound healing.

115 Lyz2(Cre+) ), we determined that MLL1 drives Tlr4 expression in diabetic macrophages by regulating le

116 C5a receptor, astrocytic-C3, and microglial-TLR4 expression in the brain.

117 Increased Tlr4 expression in the skin of Rag2(R229Q) mice is assoc

118 associated with significantly lower AGER and TLR4 expression irrespective of COPD status, possibly re

119 us tissue injury murine model, we found that TLR4 expression is dynamic in wound myeloid cells during

120 Hepatic TLR4 expression was reduced by recAP in ACLF but not acu

121 iation with increased RIP1, RIP3, pMLKL, and TLR4 expression.

122 with downregulation of Toll-like receptor 4 (TLR4) expression on the surface of macrophages.

123 Tlr4 (Tlr4(-/-) ) or myeloid-specific Tlr4 (Tlr4(f/f)Lyz2(Cre+)) resulted in improved diabetic wound

124 We examined the impact of RAGE and/or TLR4 gene deficiency in a mouse model of COPD and also d

125 TLRs, particularly TLR4, have been shown to regulate myeloid-mediated infla

126 lates system for genes Toll-like receptor-4 (TLR4), high-mobility group box 1, nuclear factor kappa b

127 ed significantly higher expression of IL-10, TLR4, high-mobility group box 1, IFN-gamma, TRIF-related

128 risk allele carriers demonstrated increased TLR4-, IFN-gamma- and IL-12-induced STAT1 and STAT4 phos

129 Downstream of TLR4, IFNbeta secretion is only vigorously triggered in

130 tural component of the Toll-like receptor 4 (TLR4) immune signal transduction pathway.

131 f which binds the cytoplasmic TIR modules of TLR4 in a manner that precludes receptor dimerization; s

132 were recruited by TRAM through activation of TLR4 in a MyD88-dependent manner.

133 is insufficient knowledge about the role of TLR4 in diabetes-associated vascular dysfunction of larg

134 and translocation to the plasma membrane of TLR4 in donor TRAMs.

135 e for MLL1-mediated epigenetic regulation of TLR4 in pathologic diabetic wound repair and suggest a t

136 es, including IL-1beta, TNF-alpha, CCL2, and TLR4 in the lumbar spinal cord.

137 une signaling and studied innately activated TLR4 in the ventral tegmental area (VTA) of selectively

138 the role of nociceptor Toll-like receptor 4 (TLR4) in OIH and priming induced by systemic low-dose mo

139 -alpha (TNFalpha), and Toll-like receptor 4 (TLR4) in surgically excised specimens from the patients

140 e immune signaling via Toll-like receptor 4 (TLR4) in the pathogenesis of dysplasia and cancer.

141 N lacking EDA, with or without a mutation in Tlr4, in our inducible mouse model of ocular hypertensio

142 ed, but not the individual, loss of TLR2 and TLR4 increased the replication of beta cells, but not th

143 le of various genes in Toll-like receptor 4 (TLR4)-induced necroptosis.

144 n as the crucial signalling intermediary for TLR4-induced glycolysis, macrophage metabolic reprogramm

145 endoplasmic reticulum-located Hrd1 regulates TLR4-induced inflammation during bacterial infection.

146 ensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflammatory response; controlled respo

147 e show that the toll-like receptors TLR2 and TLR4 inhibited the diet-induced replication of beta cell

148 TLR4 inhibition in RBP4-overexpressing mice reduces PGWA

149 Colonic LMMP of mice given the TLR4 inhibitor did not have reduced markers of neurogene

150 Treatment with TLR4 inhibitor resulted in lower liver inflammation in m

151 preterm labor, and whether a small-molecule TLR4 inhibitor, (+)-naltrexone, can mitigate adverse PAF

152 given a blocking antibody against TLR2 or a TLR4 inhibitor.

153 evidence suggests that Toll-like receptor 4 (TLR4) is a key player in the mechanisms associated with

154 nd products (RAGE) and Toll-like receptor 4 (TLR4) is implicated in COPD.

155 oral microbial composition in both TLR2 and TLR4 KO mice demonstrate that these TLRs contribute to t

156 P (YAP( KO) ) or Toll-like receptor 4 (TLR4; TLR4( KO) ), and animals were fed an HFD or treated with

157 crophage/monocyte-specific deletion of TLR4 (TLR4( KO) ).

158 -a co-receptor that confers functionality to TLR4-levels by Western blotting.

159 We here introduce a conjugation-ready TLR4 ligand, CRX-527, a potent powerful lipid A analogue

160 flagellin, administered in combination with TLR4 ligand-emulsion (GLA-SE) adjuvant.

161 role of an endogenous Toll-like receptor 4 (TLR4) ligand, fibronectin-EDA (FN-EDA), in TGFbeta2-indu

162 Synthetic TLR4 ligands thus show great promise in potentiating the

163 not the related PI4KIIbeta-impairs TIRAP and TLR4 localization to phagosomes, reduces proinflammatory

164 Mechanistically, Toll-like receptor 4 (TLR4, LPS receptor)-sphingosine kinase 1 (SphK1) signali

165 Injection of anti-human TLR4 mAbs or the anti-human IgE mAb omalizumab completel

166 Toll-like receptor 4 positive (TLR4(+) ) macrophages were higher in NASH than simple st

167 be-derived lipopolysaccharides (a ligand for TLR4), macrophages with GIV mount a more tolerant (hypo-

168 tor or bone marrow transplantation of mutant TLR4 marrow cells results in increased expression of glu

169 rane were located near critical residues for TLR4-MD-2 complex formation and TLR4-MD-2-LPS dimerizati

170 residues for TLR4-MD-2 complex formation and TLR4-MD-2-LPS dimerization.

171 of inhibition appears to involve blockade of TLR4/MD-2 protein interactions in RAW246.7 cells.

172 4/myeloid differentiation factor 2 complex (TLR4/MD-2), mouse caspase-11, and human caspases 4 and 5

173 aortic tissue to assess the co-expression of TLR4, MD2, and subunits of the vascular NADPH oxidases u

174 is study, we investigated if blockade of the TLR4-MD2 complex impacts BP and vascular function in dia

175 In summary, we show evidence that the TLR4-MD2 complex is involved in the mechanisms linking t

176 We report that (a) chronic blockade of the TLR4-MD2 complex lowers BP in diabetic animals; that (b)

177 ic endotoxemia) pathologies wherein aberrant TLR4/MD2 activation has been implicated.

178 , in a glucose-dependent manner, through the TLR4/MD2 receptor complex and TLR2.

179 receptor 4/myeloid differentiation factor-2 (TLR4/MD2) complex, leading to the release of pro-inflamm

180 receptor 4-myeloid differentiation factor 2 (TLR4/MD2).

181 d by RIPK1 kinase activity, whereas TLR3- or TLR4-mediated death was dependent on TRIF and RIPK3.

182 macrophage metabolic pathways by suppressing TLR4-mediated gene activation.

183 ng of the mechanisms underlying the aberrant TLR4-mediated increase in CP-AMPAR signaling after injur

184 s to analyze the effects of NAD(+) levels on TLR4-mediated NF-kappaB activation and NLRP3 activity, r

185 form of TLR4, their littermates, and villin-TLR4 mice backcrossed to DUOXA-knockout mice.

186 ssociated microbiota transferred from villin-TLR4 mice to wild-type germ-free mice caused increased H

187 tal cancer models were carried out in villin-TLR4 mice, carrying a constitutively active form of TLR4

188 2)O(2) was significantly increased in villin-TLR4 mice; TLR4-dependent tumorigenesis required the pre

189 asured in vivo and ex vivo Compared with NOD TLR4(+/+) mice, NOD TLR4(-/-) animals showed lower muscl

190 ), Il1alpha(-/-)/Il1beta(-/-), and Tlr2(-/-)/Tlr4(-/-) mice as well as Sprague Dawley rats for all in

191 C57BL/6 wild-type and Tlr4(-/-) mice were fed wheat- or ATI-containing diets o

192 In contrast, TLR4(-/-) mice were not protected against CS-induced neu

193 c (prediabetic) female NOD TLR4(+/+) and NOD TLR4(-/-) mice, gut morphology and microbiome compositio

194 ed EDR impairment was abolished in aortas of TLR4(-/-) mice.

195 did not increase the severity of colitis in Tlr4(-/-) mice.

196 Toll-like receptor 4 (TLR4), and AS-ODN for TLR4 mRNA administered intrathecally, attenuated HMWH-in

197 reduced both Toll-like receptor 3 (TLR3) and TLR4 mRNA expression at 6 hpi and 12 hpi.

198 g bacterial sepsis via Toll-like receptor 4 (TLR4)/MyD88 sensing of lipopolysaccharides.

199 induce a detectable Myddosome formation, the TLR4/MyD88 axis was important for phosphorylation of p38

200 ted the activation of NLRP3 inflammasome and TLR4/MyD88/NF-kappaB signaling pathways, and suppressed

201 oup box 1 (HMGB1) release activates the host TLR4/MyD88/type I interferon pathway and Batf3 dendritic

202 glia in the clearance of alpha-synuclein via TLR4-NF-kappaB-p62 mediated synucleinphagy.

203 1 induction leading to the overactivation of TLR4/NF-kappaB signaling.

204 ne pulmonary expression of key components of TLR4-NFkappaB signaling, or in the LPS-induced pulmonary

205 on IL1beta production by tumor cells through TLR4-NLRP3 inflammasome activation.

206 ated diabetes development in TLR4-deficient (TLR4(-/-)) NOD mice.

207 M-induced analgesia, and priming are neither TLR4 nor PKCepsilon dependent.

208 The peptide also affected the TLR4-(nuclear factor kappaB) signaling pathway, modulati

209 TLR4 null and EDA null mice blocked Ad5.TGFbeta-induced

210 exosomes, and exosomal HSP70 interacted with TLR4 on hair cells.

211 The discrepant effects of TLR4 on i) LNP uptake and ii) translation suggests TLR4

212 innate immune receptor Toll-like receptor 4 (TLR4) on excitability of the hippocampal dentate gyrus a

213 anism that engaged the Toll-like receptor 4 (TLR4) on hair cells to protect them from death.

214 olysaccharide (LPS) by Toll-like receptor 4 (TLR4) on macrophages induces a robust pro-inflammatory r

215 4 transcription/translocation or blockade of TLR4 or coreceptor CD14 on donor TRAMs prevented neutrop

216 pes, without reducing LNP uptake; inhibiting TLR4 or its downstream effector protein kinase R improve

217 Mechanistically, the deletion of Tlr4 or knockdown of the Ikbke gene in the hypothalamus

218 his study; and, that (c) acute inhibition of TLR4 or MD2 diminishes vascular contractility and reduce

219 eline (OR: 4.7, 95% CI: 2.3-9.7) and SNPs in TLR4 (OR: 6.5, 95% CI: 1.1-36.7) and TNFA (OR: 12.4, 95%

220 as well as genetic depletion of either Tlr4 (Tlr4(-/-) ) or myeloid-specific Tlr4 (Tlr4(f/f)Lyz2(Cre+

221 Exosomes and the HSP70/TLR4 pathway could thus provide treatment targets for th

222 LPS activated the TLR4 pathway in RAW264.7 cells as evidenced by increased

223 Pharmacological inhibition of the TLR4 pathway using a small molecule inhibitor (TAK-242)

224 crophage and platelet activation through the TLR4 pathway.

225 opolysaccharide (LPS)- toll-like receptor-4 (TLR4) pathway plays an important role in liver failure.

226 and an agonist of the Toll-like receptor 4 (TLR4) pathway.

227 Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to

228 d TNF-alpha production capacities (RIG-I and TLR4 pathways, respectively).

229 mediated decrease, demonstrating the role of TLR4-PI3-kinase signaling and providing proof-of-concept

230 TLR4(+) platelets correlated with serum LPS values.

231 ficant elevations in complement C1q, C3, and TLR4 post-RT accompanied by increased colabeling of astr

232 of histone H3 lysine 4 trimethylation on the Tlr4 promoter.

233 AHR in wild-type, RAGE(-/-) , TLR4(-/-) and TLR4(-/-) RAGE(-/-) mice following acute exposure to cig

234 TLR4(-/-) RAGE(-/-) mice were not protected against CS-i

235 TLR2 (receptor for gram-positive bacteria), TLR4 (receptor for gram-negative bacteria), or distilled

236 odulate the expression of more than 1800 LPS/TLR4-regulated genes in macrophages.

237 a) plays a key role in initiating phagosomal TLR4 responses in murine DCs by generating a phosphatidy

238 N4BP1 did not suppress TLR3 or TLR4 responses in wild-type macrophages, owing to TRIF-

239 dotoxin stimulation of Toll-like receptor 4 (TLR4), resulting in an ameliorated response after subseq

240 usly found to activate Toll-like receptor 4 (TLR4), resulting in expression of a different pattern of

241 ic model demonstrating dynamic expression of TLR4 results in altered metabolic pathways in diabetic m

242 The role of the TLR4-shaped microbiota in tumor development was tested i

243 g these previous findings, here we show that TLR4-SI expression post-CPB was associated with low seru

244 Furthermore, TLR4 signal blocking was less efficacious in limiting se

245 B. licheniformis PGA elicited more TLR4 signal than B. anthracis PGA, whereas B. subtilis P

246 st a novel mechanism in which NAD(+) affects TLR4 signal transduction.

247 When blocking of TLR4 signaling after injury was delayed, however, this t

248 DUOX2 was exquisitely dependent on TLR4 signaling and mediated the production of epithelial

249 sed, ATI-containing diets therefore activate TLR4 signaling and promote intestinal dysbiosis.

250 Paradoxically, blocking TLR4 signaling augmented both network excitability and s

251 ctions, they are all three inducible through TLR4 signaling but with distinct kinetics.

252 Increased TLR4 signaling in colitis drives expression of DUOX2 and

253 The studies identify that TLR4 signaling in neurons augments dentate granule cell

254 Blocking TLR4 signaling in vivo shortly after brain injury reduce

255 TLR4INC34 (C34), a TLR4 signaling inhibitor, suppressed IAP-induced autopha

256 creasing sirtuin 1 levels and inhibiting the TLR4 signaling pathway.

257 Suppression of both RIG-I and TLR4 signaling pathways, essential for respective antivi

258 r the responses in Nr1i2(-/-) mice, blocking TLR4 signaling significantly reduced TcdA/B-induced dise

259 The inhibition of TLR4 signaling warrants further investigation as a candi

260 This process was mediated by TLR4 signaling, as revealed by pharmacological blockade

261 nt study, we interrogate the intersection of TLR4 signaling, epithelial redox activity, and the micro

262 a sex difference in pulmonary innate immune TLR4 signaling, lung injury and subsequent abnormal lung

263 We observed that during TLR4 signaling, necrosome activation is mediated through

264 y when AMPAR currents, downstream targets of TLR4 signaling, were transiently enhanced.

265 In contrast, during tonic TLR4 signaling, WT cells did not undergo necroptosis, ev

266 and interleukin-6 mediated through TLR2 and TLR4 signaling.

267 ependent activation of toll-like receptor 4 (TLR4) signaling and subsequent engagement of the NLRP3 i

268 d regulation of Toll-like receptor (TLR2 and TLR4) signaling in dendritic cells, but not in macrophag

269 through the MyD88 and TRIF/TRAM arms of the TLR4-signaling pathway was observed.

270 Inhibition of RAGE but not TLR4 signalling may protect against airway neutrophilia

271 No relation to AAA risk was found for TLR4 SNPs.

272 luence diabetic macrophage responsiveness to TLR4 stimulation and inhibit tissue repair.

273 duction of cytokines in response to TLR3 and TLR4 stimulation of caspase-8-deficient macrophages(13)

274 graphy (GC), SDS-PAGE, Toll-like receptor 4 (TLR4) stimulation, and immunoblot analysis were performe

275 done by others, our simulations showed that TLR4 structure was well maintained with stable interface

276 focused primarily on activating the TLR3 or TLR4 subtypes, to mimic immune responses to viral or bac

277 Our results suggest that the activation of TLR4 supports tumor progression by stimulating the relea

278 e observed enhanced degradation of TIRAP and TLR4 suppression by cytoplasmic linker protein 170 in th

279 Toll-like receptors (TLRs) such as TLR2 and TLR4 survey the extracellular environment for pathogens.

280 ce, carrying a constitutively active form of TLR4, their littermates, and villin-TLR4 mice backcrosse

281 following activation of three TLR pathways (TLR4, TLR1/2, and TLR7/8) or infection with influenza A

282 wabs collected from 12- to 14-week-old TLR2, TLR4, TLR2/4 double knock-out (KO) mice using a MiSeq pl

283 by macrophage/monocyte-specific deletion of TLR4 (TLR4( KO) ).

284 -242) as well as genetic depletion of either Tlr4 (Tlr4(-/-) ) or myeloid-specific Tlr4 (Tlr4(f/f)Lyz

285 either Tlr4 (Tlr4(-/-) ) or myeloid-specific Tlr4 (Tlr4(f/f)Lyz2(Cre+)) resulted in improved diabetic

286 of YAP (YAP( KO) ) or Toll-like receptor 4 (TLR4; TLR4( KO) ), and animals were fed an HFD or treate

287 caused by sterile hemolysis in mice required TLR4, TNFR1, and mitochondrial ROS, supporting the ratio

288 Furthermore, CCN1 binds directly to TLR2 and TLR4 to activate MyD88-dependent signaling, cytokine exp

289 OS or inhibiting their production to prevent TLR4 transcription/translocation or blockade of TLR4 or

290 rs MaIL1 as an integral RNA component of the TLR4-TRIF pathway and predicts further RNAs to be requir

291 ned that IFN-beta expression was induced via TLR4-TRIF signaling.

292 Activation of epithelial TLR4 was associated with up-regulation of DUOX2 and NOX1

293 t the transcriptional response downstream of TLR4 was intact in cells lacking Mm47.

294 tified, and the downstream signal pathway of TLR4 was investigated with Western blot and proteomic an

295 blotting revealed that protein expression of TLR4 was markedly increased in microglia at 24 h after S

296 cific expression of the known HSP70 receptor TLR4 was required for the protective effect of exosomes,

297 Interleukin-1beta (IL-1beta), TNFalpha, and TLR4 were evaluated in the corneas of the mice with fung

298 presence of microglial Toll-like receptor 4 (TLR4), which induces transcriptional upregulation of p62

299 s is associated with upregulation of hepatic TLR4, which explains susceptibility to development of AC

300 masome, most likely driven by interaction of TLR4 with rickettsial LPS, contributes to host protectiv